JP2025160233A5 - - Google Patents

Info

Publication number
JP2025160233A5
JP2025160233A5 JP2025116467A JP2025116467A JP2025160233A5 JP 2025160233 A5 JP2025160233 A5 JP 2025160233A5 JP 2025116467 A JP2025116467 A JP 2025116467A JP 2025116467 A JP2025116467 A JP 2025116467A JP 2025160233 A5 JP2025160233 A5 JP 2025160233A5
Authority
JP
Japan
Prior art keywords
ppm
concentration
composition according
deoxycytidine
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025116467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025160233A (ja
Filing date
Publication date
Priority claimed from JP2022510955A external-priority patent/JP7769603B2/ja
Application filed filed Critical
Publication of JP2025160233A publication Critical patent/JP2025160233A/ja
Publication of JP2025160233A5 publication Critical patent/JP2025160233A5/ja
Pending legal-status Critical Current

Links

JP2025116467A 2019-08-19 2025-07-10 デオキシシチジンの多形形態、それを含む組成物および使用 Pending JP2025160233A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962888893P 2019-08-19 2019-08-19
US62/888,893 2019-08-19
JP2022510955A JP7769603B2 (ja) 2019-08-19 2020-08-19 デオキシシチジンの多形形態、それを含む組成物および使用
PCT/US2020/047047 WO2021034962A1 (en) 2019-08-19 2020-08-19 Polymorphic forms of deoxycytidine, compositions comprising the same and uses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022510955A Division JP7769603B2 (ja) 2019-08-19 2020-08-19 デオキシシチジンの多形形態、それを含む組成物および使用

Publications (2)

Publication Number Publication Date
JP2025160233A JP2025160233A (ja) 2025-10-22
JP2025160233A5 true JP2025160233A5 (cg-RX-API-DMAC7.html) 2026-04-13

Family

ID=74647126

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022510955A Active JP7769603B2 (ja) 2019-08-19 2020-08-19 デオキシシチジンの多形形態、それを含む組成物および使用
JP2025116467A Pending JP2025160233A (ja) 2019-08-19 2025-07-10 デオキシシチジンの多形形態、それを含む組成物および使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022510955A Active JP7769603B2 (ja) 2019-08-19 2020-08-19 デオキシシチジンの多形形態、それを含む組成物および使用

Country Status (8)

Country Link
US (1) US11649259B2 (cg-RX-API-DMAC7.html)
EP (1) EP4017502A4 (cg-RX-API-DMAC7.html)
JP (2) JP7769603B2 (cg-RX-API-DMAC7.html)
CN (1) CN114929240B (cg-RX-API-DMAC7.html)
AU (1) AU2020334060B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022002513A2 (cg-RX-API-DMAC7.html)
CA (1) CA3150755A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021034962A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022204555A1 (en) * 2021-03-26 2022-09-29 Zogenix Mds, Inc. Aqueous solutions containing purines and pyrimidines and uses thereof
WO2026082601A2 (en) * 2024-10-15 2026-04-23 UCB Biopharma SRL Method of purification

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898936A (en) * 1984-09-24 1990-02-06 Pcr, Inc. 2-deoxyuridines and riboside precursors
JPS61135597A (ja) * 1984-12-06 1986-06-23 Takeda Chem Ind Ltd シチジンおよびデオキシシチジンの製造法
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
JP2002255991A (ja) * 2000-12-27 2002-09-11 Mitsui Chemicals Inc 保護化2’−デオキシシチジン誘導体の製造法
JP2002293791A (ja) * 2001-03-30 2002-10-09 Mitsui Chemicals Inc 保護化2’−デオキシシチジン誘導体の精製法
CN100424091C (zh) * 2002-06-05 2008-10-08 三井化学株式会社 保护化2’-脱氧胞苷类的精制法
EP1551838B1 (en) * 2002-10-16 2006-08-09 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US9669048B2 (en) * 2012-10-25 2017-06-06 Fresenius Kabi Oncology Limited Stable pharmaceutical composition of 5-aza-2′-deoxycitidine
WO2016205671A1 (en) 2015-06-17 2016-12-22 The Trustees Of Columbia University In The City Of New York Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial dna depletion syndromes
GB2580963C (en) * 2019-02-01 2025-09-03 Hemispherian As Cancer therapies

Similar Documents

Publication Publication Date Title
JP7253866B1 (ja) トリアジン誘導体を含有する経口投与する製剤
US20170022194A1 (en) Stable crystalline noribogaine salt ansolvates
JP2025531807A (ja) 細胞傷害性イミダゾ[1,2-a]ピリジン化合物及び治療におけるその使用
PT100234B (pt) Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao
CA2744231A1 (en) Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
JPH02131425A (ja) 抗ウイルス剤
JP2021535111A5 (cg-RX-API-DMAC7.html)
JP2004528336A (ja) アジスロマイシン水和物の1,2−プロピレングリコール包接化合物、その製造方法およびそれを含む医薬組成物
JP2025160233A (ja) デオキシシチジンの多形形態、それを含む組成物および使用
JPS6249270B2 (cg-RX-API-DMAC7.html)
CN109485676A (zh) 用于抗病毒的新型核苷类逆转录酶抑制剂
JP2012521417A (ja) アデフォビルジピボキシルの新規結晶形及びその製造方法
JPS5823866B2 (ja) ウレアおよびチオウレア誘導体
WO2005027856A2 (en) Inhibitors of anthrax lethal factor
CA3215792A1 (en) Processes for the synthesis of valbenazine
CA2582778A1 (fr) Derives de pyridine, leur preparation, leur application en therapeutique
JPH0322394B2 (cg-RX-API-DMAC7.html)
TWI239327B (en) Aminohydroxylation of olefins in the presence of acetamide
CN116492363A (zh) 新的核苷氨基磷酸脂化合物的组合物及其制备方法
Miller III et al. The Pharmacological Activities of the Metabolites of N‐[(Trimethylamineboryl)‐Carbonyl]‐L‐Phenylalanine Methyl Ester
US9328061B2 (en) Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols
CA2315835C (en) New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester
JP2024546397A (ja) 4’-置換ヌクレオシドの結晶、その製造方法、組成物及び使用
TW202532060A (zh) 醫藥組成物
JP2009505945A5 (cg-RX-API-DMAC7.html)